Get in touch
First-in-class host-targeting antiviral therapies against severe respiratory viral infections, including COVID-19 and influenza.
Invest in research to contribute to pandemic preparedness!
Learn more about the team behind ATRIVA Therapeutics GmbH.
Novel host-targeting approach to prevent viral replication.
Financing and business development opportunities.
Please note that, due to the current coronavirus crisis, many conferences have been canceled or postponed.
Feel free to contact us any time.
About Us Contact Legal Notice Data Protection
Atriva Therapeutics GmbH Eisenbahnstr. 1, 72072 Tübingen
+49 (0)7071 8597673 firstname.lastname@example.org
Copyright © 2020 Atriva Therapeutics GmbH